Clinical trials
Coronary Artery Disease trials in Norway
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
62 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 3 |
| 2003 | 2 |
| 2004 | 1 |
| 2005 | 6 |
| 2006 | 4 |
| 2007 | 1 |
| 2008 | 4 |
| 2009 | 2 |
| 2010 | 3 |
| 2011 | 2 |
| 2012 | 6 |
| 2013 | 3 |
| 2014 | 1 |
| 2015 | 1 |
| 2017 | 3 |
| 2018 | 4 |
| 2019 | 1 |
| 2020 | 2 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 39 |
| Active, not recruiting | 7 |
| Recruiting | 6 |
| Unknown status | 6 |
| Terminated | 4 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Oslo University Hospital | 12 |
| Norwegian University of Science and Technology | 7 |
| Haukeland University Hospital | 6 |
| Helse Stavanger HF | 5 |
| Abbott Medical Devices | 3 |
| AstraZeneca | 3 |
| CSL Behring | 2 |
| University Hospital of North Norway | 2 |
| University of Bergen | 2 |
| Vestre Viken Hospital Trust | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Coronary Artery Disease | 62 |
| Myocardial Infarction | 10 |
| Angina, Unstable | 5 |
| Atherosclerosis | 5 |
| Acute Coronary Syndrome | 4 |
| Cardiovascular Diseases | 4 |
| Diabetes Mellitus | 4 |
| Diabetes Mellitus, Type 2 | 4 |
| Myocardial Ischemia | 4 |
| Angina Pectoris | 3 |
Trials
Showing 26 to 50 of 62. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.